Advertisement

NEXT ARTICLE

Soy isoflavone supplements do not reduce breast cancer cell proliferation

19:44 EST 3 Feb 2012 | The Medical News

Soy isoflavone supplements did not decrease breast cancer cell proliferation in a randomized clinical trial, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.

Original Article: Soy isoflavone supplements do not reduce breast cancer cell proliferation

The Medical News

 Channels 189 Associated Channels :: Search

  • Epithelial cell adhesion molecule EpCAM CD326

    Epithelial cell adhesion molecule (EpCAM; CD326) is a cell surface protein that is frequently expressed at high level on most solid tumor types, including prostate, breast, colon, gastric, ovarian,...

  • Breast Cancer

    Breast cancer in the UK is diagnosed in nearly  46,000 people  each year, with just over 12,000 dying from breast cancer each year in he UK. There are several risk factors for developing b...

  • Selective Estrogen Receptor Modulators SERMs

    Selective estrogen receptor modulators (SERMs) act as estrogen receptor (ER) agonists or antagonist depending on the targeted tissue and the specific configuration of the used SERM. Effects on bone, e...

  • Neoadjuvant therapy

    Neoadjuvant therapy is the administration of therapeutic agents before the main treatment. One example is neoadjuvant hormone therapy prior to radical radiotherapy for adenocarcinoma of the prostate...

  • Lung Cancer

    Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common ca...

  • Squamous cell cancer of the anus and vulva

  • Cancer

    Cancer (malignant neoplasm) is a class of disease. There are malignancy properties that cancer cells have;  1. The diseased tissue grows uncontrollably, ignoring growth arrest signals, ...

  • Diet and supplements

  • Dietary Supplements

  • Hypoxia Inducible Factor HIF

    Hypoxia-inducible factor 1 (HIF-1) is a key regulator of angiogenic and glucose metabolism processes utilised by tumour cells for survival and growth under hypoxic conditions. While HIF-1α prote...

Associated Content for this Article